Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Guruceaga

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Cancer Letters|March 26, 2019
Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machineryFrancisco Exposito, Maria Villalba, Miriam Redrado, et al.
Plos One|February 15, 2013
Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in miceCatalina Atorrasagasti, Estanislao Peixoto, Jorge B Aquino, et al.
Cancer Letters|October 9, 2019
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicityCarmen Vicente, Elena Arriazu, Elena Martínez-Balsalobre, et al.
Frontiers in Immunology|October 27, 2022
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccinationDavid Repáraz, Marta Ruiz, Leyre Silva, et al.
Plos One|December 28, 2017
Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genomeJuan Roberto Rodriguez-Madoz, Edurne San Jose-Eneriz, Obdulia Rabal, et al.
Ebiomedicine|March 2, 2020
FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacyÁlvaro Quintanal-Villalonga, Irene Ferrer, Elizabeth Guruceaga, et al.
Archives of Clinical and Biomedical Research|September 9, 2020
miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCsArlet María Acanda de la Rocha, Marisol González-Huarriz, Elizabeth Guruceaga, et al.
Plos One|October 25, 2013
Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cellsBeatriz Aldaz, Ainara Sagardoy, Lorena Nogueira, et al.
Archives of Clinical and Biomedical Research|December 10, 2021
Erratum: miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCsArlet María Acanda de la Rocha, Marisol González-Huarriz, Elizabeth Guruceaga, et al.
International Journal of Molecular Sciences|December 11, 2025
Transcriptomic Changes Underlying the Anti-Steatotic Effects of DHA Supplementation in Aged Obese Female MiceÁlvaro Pejenaute Martínez de Lizarrondo, Paula Martín-Climent, María Martínez-Rubio, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Cancer Letters|March 26, 2019
Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machineryFrancisco Exposito, Maria Villalba, Miriam Redrado, et al.
Plos One|February 15, 2013
Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in miceCatalina Atorrasagasti, Estanislao Peixoto, Jorge B Aquino, et al.
Cancer Letters|October 9, 2019
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicityCarmen Vicente, Elena Arriazu, Elena Martínez-Balsalobre, et al.
Frontiers in Immunology|October 27, 2022
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccinationDavid Repáraz, Marta Ruiz, Leyre Silva, et al.
Plos One|December 28, 2017
Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genomeJuan Roberto Rodriguez-Madoz, Edurne San Jose-Eneriz, Obdulia Rabal, et al.
Ebiomedicine|March 2, 2020
FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacyÁlvaro Quintanal-Villalonga, Irene Ferrer, Elizabeth Guruceaga, et al.
Archives of Clinical and Biomedical Research|September 9, 2020
miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCsArlet María Acanda de la Rocha, Marisol González-Huarriz, Elizabeth Guruceaga, et al.
Plos One|October 25, 2013
Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cellsBeatriz Aldaz, Ainara Sagardoy, Lorena Nogueira, et al.
Archives of Clinical and Biomedical Research|December 10, 2021
Erratum: miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCsArlet María Acanda de la Rocha, Marisol González-Huarriz, Elizabeth Guruceaga, et al.
International Journal of Molecular Sciences|December 11, 2025
Transcriptomic Changes Underlying the Anti-Steatotic Effects of DHA Supplementation in Aged Obese Female MiceÁlvaro Pejenaute Martínez de Lizarrondo, Paula Martín-Climent, María Martínez-Rubio, et al.
Pageof 8